Literature DB >> 8869937

Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis.

V R Deutsch1, A Eldor, T Olson, V Barak, M Pick, A Nagler.   

Abstract

Plasma obtained from lethally irradiated animals contains a megakaryocyte (MK) growth factor which has recently been identified as the ligand for the c-mpl receptor and has been named thrombopoietin (TPO). We demonstrate that post-irradiation aplastic canine plasma (PICS-J) and plasma from a human subject (ML) who was accidentally exposed to lethal irradiation, contain high levels of this activity, which support both MK proliferation and maturation in a dose-dependent manner. These plasma were far more active in stimulating human MK colony formation than other types of thrombocytopenic plasma or a number of exogenously added human recombinant cytokines and their combinations. The addition of stem cell factor (SCF), which alone has a minimal stimulatory affect, to post lethal-irradiation plasma provided a synergistic stimulation of megakaryocytopoiesis both in colony assays and liquid cultures. In colony assays, the combination of SCF with PICS-J or ML almost doubled the number of burst forming units (BFU-MK) and provided a 1.5-fold increase in colony forming units (CFU-MK). A 1.6-fold increase in the number of CD34+ BM cell-derived MK colonies was also elicited. In liquid cultures, the presence of both SCF and PICS-J or ML induced the appearance of a high proportion of CD34+ (6.56% vs 0.6% control) and CD41+ (3.5% vs 1.2% control) cells after 3 days in culture. By day 10, 66.8 x 10(4) CD41+ cells and 29.8 x 10(4) CD34+ cells were derived from 2 x 10(6) BMMC originally seeded. We propose that these unique plasma, which do not contain elevated level of IL-6, IL-3, GM-CSF, IL-1 beta, erythropoietin or SCF, probably contain high levels of TPO. The addition of SCF to the post-irradiation plasma provides a synergistic stimulation of megakaryocytopoiesis which may become relevant for future clinical application.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869937     DOI: 10.1007/bf02988839

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  42 in total

Review 1.  Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia.

Authors:  M S Gordon; R Hoffman
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

2.  Increase in circulating megakaryocyte growth-promoting activity (Meg-GPA) following sublethal irradiation is not related to decreased platelets.

Authors:  M Miura; C W Jackson; S A Steward
Journal:  Exp Hematol       Date:  1988-02       Impact factor: 3.084

Review 3.  Regulation of megakaryocytopoiesis.

Authors:  H Avraham
Journal:  Stem Cells       Date:  1993-11       Impact factor: 6.277

4.  Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells.

Authors:  N Debili; J M Massé; A Katz; J Guichard; J Breton-Gorius; W Vainchenker
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

5.  Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies.

Authors:  R Hoffman; E Mazur; E Bruno; V Floyd
Journal:  N Engl J Med       Date:  1981-09-03       Impact factor: 91.245

6.  Regulation of human megakaryocytopoiesis. An in vito analysis.

Authors:  E M Mazur; R Hoffman; E Bruno
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

7.  Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro.

Authors:  A Nagler; A Eldor; E Naparstek; M Mumcuoglu; S Slavin; V R Deutsch
Journal:  Exp Hematol       Date:  1995-11       Impact factor: 3.084

8.  Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.

Authors:  V C Broudy; N L Lin; K Kaushansky
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

9.  Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit.

Authors:  D J Kuter; R D Rosenberg
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.

Authors:  M S Cairo; J M Plunkett; P Schendel; C van de Ven
Journal:  Exp Hematol       Date:  1994-10       Impact factor: 3.084

View more
  1 in total

1.  Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities.

Authors:  A Toren; R Nagler; A Nagler
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.